APA

Stocker S. L., Morrissey K. M., Yee S. W., Castro R. A., Xu L., Dahlin A., Ramirez A. H., Roden D. M., Wilke R. A., McCarty C. A., Davis R. L., Brett C. M. & Giacomini K. M. (20130226). The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. : Clinical pharmacology and therapeutics.

Chicago

Stocker S L, Morrissey K M, Yee S W, Castro R A, Xu L, Dahlin A, Ramirez A H, Roden D M, Wilke R A, McCarty C A, Davis R L, Brett C M and Giacomini K M. 20130226. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. : Clinical pharmacology and therapeutics.

Harvard

Stocker S. L., Morrissey K. M., Yee S. W., Castro R. A., Xu L., Dahlin A., Ramirez A. H., Roden D. M., Wilke R. A., McCarty C. A., Davis R. L., Brett C. M. and Giacomini K. M. (20130226). The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. : Clinical pharmacology and therapeutics.

MLA

Stocker S L, Morrissey K M, Yee S W, Castro R A, Xu L, Dahlin A, Ramirez A H, Roden D M, Wilke R A, McCarty C A, Davis R L, Brett C M and Giacomini K M. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. : Clinical pharmacology and therapeutics. 20130226.